Cite

    Choquette, D. et al. (n.d.). AB0397 Abatacept shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry. Annals of the rheumatic diseases. p. 1188. [Online].